CD200 and neoplasm: Upon interaction with its receptor CD200R1, CD200 triggers an immunosuppressive signal, leading to macrophage inhibition, regulatory T-cell induction, cytokine profile switching from Th1 to Th2, and eventually, inhibition of tumor-specific T-cell immunity [12,13].